| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $15.2M | $25.9M | $24.1M |
| YoY Revenue Growth % | -41.5% | +7.7% | — |
| Gross Profit | $7.2M | $9.5M | — |
| Gross Margin % | 47.7% | 36.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$23.4M | -$29.3M | -$48.3M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$22.1M | -$26.4M | -$43.9M |
| EBITDA (Normalized) | -$22.6M | -$28.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $5.3M | -$19.1M | -$29.9M |
| Capital Expenditures (CapEx) | $981.0K | $1.3M | — |
| Free Cash Flow (FCF) | $4.4M | -$20.4M | -$29.9M |
| FCF Margin % | 28.7% | -78.5% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $35.2M | $32.1M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $41.0M | $53.9M | — |